Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

esomeprazole topical cream

A topical cream formulation containing the proton pump inhibitor (PPI) esomeprazole, with potential antioxidant, anti-inflammatory and antifibrotic activities. Upon topical administration, esomeprazole inhibits the enzyme dimethylarginine dimethylaminohydrolase (DDAH), which increases the levels of the nitric oxide synthase (NOS) inhibitor asymmetric dimethylarginine (ADMA). In addition, esomeprazole increases the expression of the antioxidant enzyme heme oxygenase-1 (HO-1). Together, these actions reduce oxidative stress which may protect cells from reactive oxygen species (ROS), cellular damage, inflammation and fibrosis.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	dermaprazole

esomeprazole topical cream

Search NCI's Drug Dictionary